EUVIMEDEUVIMED entdecken
ÜbersichtsarbeitSystematische ÜbersichtMetaanalyseOpen Access · CC BY 4.0

Intragastric balloon for obesity treatment: Systematic review and meta-analysis of randomized controlled trials

Gabriel de Oliveira Amaral iD, João Pedro Schmitt iD, Lucas Monteiro Delgado iD, Gilmara Coelho Meine iD

Endoscopy International Open · 03.09.2025 · 13 (CP)

DOI: 10.1055/a-2681-2859 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift Endoscopy International Open, erschienen am 03.09.2025. Verfasst von Gabriel de Oliveira Amaral und 3 weiteren Autor:innen. Beteiligte Einrichtung: Department of Medicine, FEEVALE University, Novo Hamburgo, Brazil. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 37 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Intragastric balloon (IGB) is a minimally invasive and reversible endoscopic option for treating obesity. This systematic review and meta-analysis compared the effectiveness of IGB versus standard medical therapy (SMT) for obesity management, including studies with a minimum treatment duration of 6 months. Subgroup analyses were performed based on IGB type, baseline mean body mass index (BMI), and use of pharmacological therapy in the SMT group. We searched for randomized controlled trials (RCTs) in MEDLINE, EMBASE, and Cochrane Library databases. Outcomes were evaluated at 6, 9, and 12 months after initiation of treatment. A random-effects model was used to calculate the pooled mean difference (MD) with 95% confidence interval (CI) for continuous outcomes. We included 15 RCTs (1961 patients). Compared with SMT, IGB significantly improved the percentage of excess weight loss at 6 months (MD 16.80; 95% CI 9.22–24.38), 9 months (MD 14.36; 95% CI 7.67–21.04), and 12 months (MD 13.10; 95% CI 10.43–15.77). IGB also showed superior results in percentage of total weight loss, absolute weight loss, and BMI reduction at all time points compared with SMT. There were significant subgroup differences for some outcomes according to IGB type and baseline mean BMI. In obese adults, IGB is more effective than SMT for weight loss at 6, 9, and 12 months.

Schlagwörter

Stichwörter der Autor:innen

Endoscopy Upper GI TractEpidemiologyStatistics

Autor:innen und Institutionen

  • Department of Medicine, FEEVALE University, Novo Hamburgo, Brazil.
  • Medicine, Universidade Federal de Minas Gerais, Belo Horizonte, Brazil.
  • Health Sciences Institute / Medical School, Universidade FEEVALE, Novo Hamburgo, Brazil.

ORCID-Profile: Gabriel de Oliveira Amaral, João Pedro Schmitt, Lucas Monteiro Delgado, Gilmara Coelho Meine

Zitieren

APA

Amaral, G. O., Schmitt, J. P., Delgado, L. M., & Meine, G. C. (2025). Intragastric balloon for obesity treatment: Systematic review and meta-analysis of randomized controlled trials. Endoscopy International Open, 13(CP). https://doi.org/10.1055/a-2681-2859

Vancouver

Amaral GO, Schmitt JP, Delgado LM, Meine GC. Intragastric balloon for obesity treatment: Systematic review and meta-analysis of randomized controlled trials. Endoscopy International Open. 2025;13(CP). doi:10.1055/a-2681-2859

BibTeX
@article{Amaral2025,
  author = {Amaral, Gabriel de Oliveira and Schmitt, João Pedro and Delgado, Lucas Monteiro and Meine, Gilmara Coelho},
  title = {Intragastric balloon for obesity treatment: Systematic review and meta-analysis of randomized controlled trials},
  journal = {Endoscopy International Open},
  year = {2025},
  volume = {13},
  number = {CP},
  doi = {10.1055/a-2681-2859}
}
Kostenlos starten →